Search

Author/Creator Driessen, R

1. P4197Evolution of vasomotor function and myocardial perfusion during three years follow-up after randomization between bioresorbable vascular scaffold and metal drug eluting stent: the VANISH trial. (28th August 2018)

Authors:
Stuijfzand, W; Schumacher, S; Driessen, R; Lammertsma, A; Van Rossum, A C; Van De Ven, P; Nap, A C; Appelman, J; Lemkes, J; Van Leeuwen, M; Van Royen, N; Raijmakers, P; Knaapen, P
Journal:
European heart journal
Issue:
Volume 39(2018)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. First 12-month follow-up of bioresorbable synthetic heart valves implanted in the aortic position in sheep. (3rd October 2022)

Authors:
Vis, A; De Kort, B J; Szymczyk, W; Van Rijswijk, J W; Dekker, S; Driessen, R; Wijkstra, N; Grundeman, P F; Niessen, H W M; Janssen, H M; Dankers, P Y W; Smits, A I P M; Bouten, C V C; Kluin, J
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Machine learning from quantitative coronary computed tomography angiography predicts ischemia and impaired myocardial blood flow. (14th October 2021)

Authors:
Lin, A; Van Diemen, P; Motwani, M; McElhinney, P; Otaki, Y; Han, D; Kwan, A; Tzolos, E; Cadet, S; Danad, I; Driessen, R; Slomka, P J; Berman, D S; Dey, D; Knaapen, P
Journal:
European heart journal
Issue:
Volume 42(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗